There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Valneva (VALN – Research Report) and Roivant Sciences (ROIV – Research Report) with bullish sentiments.
Valneva (VALN)
H.C. Wainwright analyst Edward White maintained a Buy rating on Valneva today and set a price target of $26.00. The company’s shares closed last Friday at $11.54.
According to TipRanks.com, White has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Valneva is a Moderate Buy with an average price target of $26.00.
See today’s best-performing stocks on TipRanks >>
Roivant Sciences (ROIV)
Goldman Sachs analyst Corinne Jenkins maintained a Buy rating on Roivant Sciences today and set a price target of $14.00. The company’s shares closed last Friday at $9.13.
According to TipRanks.com, Jenkins is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Roivant Sciences with a $16.13 average price target, implying a 78.6% upside from current levels. In a report issued on November 13, TD Cowen also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on VALN:
